AMOEBA (EPA:AMEBA) - Amoeba signs a Letter of Intent with H2O FACILITIES.

Transparency directive : regulatory news

08/11/2017 17:45

PRESS RELEASE

              AMOEBA signs a Letter of Intent with H2O FACILITIES
                For the distribution of BIOMEBA in Switzerland

Lyon (France), Lancy (Switzerland), November 8th, 2017 - AMOEBA (FR0011051598 -
AMEBA), producer of a biological biocide capable of eliminating bacterial risk
in water and wound care applications, announced today that it has signed a
Letter of Intent (LOI) with H2O FACILITIES prior to entering into a definitive
agreement regarding the distribution of its product in Switzerland, pending
marketing authorization.

The signature of this agreement allows AMOEBA to extend its commercial cover in
Europe for the distribution of the green biocide BIOMEBA in the regions of
Geneva and Lausanne where the luxury goods industry and the tertiary sector are
predominant.

H2O FACILITIES is a major player in water treatment and offers a global service
on more than 300 cooling towers in the French-speaking region of Switzerland.

"We are very happy to be able to offer this innovative solution to our
customers. We already know that some of them want to test the BIOMEBA product
in order to treat the water of their towers in an ecological manner." said
Didier MENOUD, GENERAL MANAGER of H2O FACILITIES.

"With this new LOI, AMOEBA continues to develop its commercial network in
Europe. Switzerland is a country sensitive to environmental issues and water
preservation. With BIOMEBA, we intend to provide a concrete solution to
end-users." stated Fabrice PLASSON, CEO of AMOEBA.

About H2O FACILITIES:

H2O FACILITIES SA was founded by Mr Rittener, Mr Menoud and Mr Bezzoli, who
have over 60 years' experience in the field of water treatment. The company
includes about twenty qualified technicians, each equipped with a service van
allowing quick and effective interventions. Our range of exclusive products
FINEAMIN and SANICLINE covers all needs for the conditioning of domestic hot
water networks, cooling towers, air conditioning and heating. More information
on www.h2o-f.ch

About AMOEBA:

AMOEBA group's objective is to become the global leader in eliminating
waterborne bacterial risk in water treatment and wound care applications. Our
solutions represent alternatives to chemical products widely used in the
cooling water treatment and the wound care market. In a global market for
chemical biocides estimated to be worth EUR 21 bn(1) AMOEBA is focusing on the
industrial cooling tower application estimated at EUR 1.7 bn(2). Similarly, in
a global wound care market estimated at EUR 15.2bn(3), AMOEBA is targeting the
chronic wound care market in the USA, estimated to be worth EUR 751 million(4).
The use of Willaertia magna C2c Maky in health care products will be subject to
FDA (Food and Drug Administration) clearance in the USA. AMOEBA's biological
biocide for water treatment, BIOMEBA, has not yet been granted marketing
authorization in the USA, Europe and Canada. AMOEBA is taking the required
regulatory steps to be granted marketing authorization in those regions for the
use of BIOMEBA in cooling water systems. Based in Chassieu (Lyon, France),
AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and
joined the CAC(r) Small index on 21st September 2015. More information on
www.amoeba-biocide.com.

(1): Sources combined by Amoeba from water treatment agencies, Freedonia,
     Eurostat and MarketsandMarkets
(2): Amoeba data combined from the following sources: DRIRE 2013, Eurostat,
     ARHIA 2013
(3): marketsandmarkets.com, "Wound Care Market by Product, Wound Type, End
     User - Global Forecast to 2021," 2016.
(4): BCC Research, "Markets for Advanced Wound Management Technologies,"
     Wellesley, MA, 2017.

Contacts:

Amoéba
Nathalie COMBROUSSE
Marketing Communication Manager
Tel. : +33 (0)4 81 09 18 15
nathalie.combrousse@amoeba-biocide.com

Actifin
Ghislaine GASPARETTO
Financial Communication
Tel. : +33 (0)1 56 88 11 11
ggasparetto@actifin.fr

source : webdisclosure.com

AMOEBA's latest news

07/10/2024 17:45

AMOEBA (EPA:AMEBA) - Amoeba signs a Letter of Intent with H2O FACILITIES.

Transparency directive : regulatory news

AMOEBA's latest news

Other stories